Add like
Add dislike
Add to saved papers

Psychological Well-being during Pregnancy: The Contribution of Stress Factors and Maternal-Fetal Bonding.

BACKGROUND: Pregnancy and anticipation of the birth of the first child is considered a happy and exciting time. However, the stress involved in pregnancy has been found to put women at greater risk of impaired psychological well-being, or higher distress. Confusion in the theoretical literature between the terms 'stress' and 'distress' makes it difficult to understand the underlying mechanism that may enhance or reduce psychological well-being. We suggest that maintaining this theoretical distinction and examining stress from different sources, may allow us to gain new knowledge regarding the psychological well-being of pregnant women.

OBJECTIVE: Drawing on the Calming Cycle Theory, to examine a moderated mediation model for the explanation of the dynamic between two stress factors (COVID-19-related anxiety and pregnancy stress) that may pose a risk to psychological well-being, as well as the protective role of maternal-fetal bonding.

METHODS: The sample consisted of 1,378 pregnant women who were expecting their first child, recruited through social media and completed self-report questionnaires.

RESULTS: The higher the COVID-19-related anxiety, the higher the pregnancy stress, which, in turn, was associated with lower psychological well-being. However, this effect was weaker among women who reported greater maternal-fetal bonding.

CONCLUSION: The study expands knowledge of the dynamic between stress factors and psychological well-being during pregnancy, and sheds light on the unexplored role of maternal-fetal bonding as a protective factor against stress.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app